Could interferon still play a role in metastatic renal cell carcinoma? A randomized study of two schedules of sorafenib plus interferon-alpha 2a (RAPSODY). (Q42667210)
Jump to navigation
Jump to search
scientific article published on 23 August 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Could interferon still play a role in metastatic renal cell carcinoma? A randomized study of two schedules of sorafenib plus interferon-alpha 2a (RAPSODY). |
scientific article published on 23 August 2012 |
Statements
Could interferon still play a role in metastatic renal cell carcinoma? A randomized study of two schedules of sorafenib plus interferon-alpha 2a (RAPSODY) (English)
Armando Santoro
1 reference
Sergio Bracarda
Corrado Boni
Claudia Mucciarini
Antonio Pazzola
Enrico Cortesi
Donatello Gasparro
Francesco Di Costanzo
Michela Cinquini
Claudia Caserta
Chiara Paglino
Verena De Angelis
23 August 2012